Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC17 (Folate-hapten Conjugate) in Metastatic Renal Cell Carcinoma
NCT00485563Phase 2Terminated
- Sponsor
- Endocyte
- Start
- Jun 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of EC-17 in renal cell carcinoma (RCC), sponsored by Endocyte. Started Jun 2007; status: terminated.
02
Drugs
EC-17
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00485563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00485563.